| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antiretrovirals for HIV prevention: translating promise into praxis
|
Mayer, Kenneth H
|
|
2011
|
378 |
9787 |
p. 206-208
3 p.
|
artikel
|
| 2 |
A strategic revolution in HIV and global health
|
England, Roger
|
|
2011
|
378 |
9787 |
p. 226-
1 p.
|
artikel
|
| 3 |
Battles with donors cloud Malawi's HIV prevention plan
|
Donnelly, John
|
|
2011
|
378 |
9787 |
p. 215-216
2 p.
|
artikel
|
| 4 |
Bertrand Audoin: promoting a global strategy for IAS
|
Samarasekera, Udani
|
|
2011
|
378 |
9787 |
p. 218-
1 p.
|
artikel
|
| 5 |
Body-mass index, abdominal adiposity, and cardiovascular risk
|
Gonçalves, Frederico Bastos
|
|
2011
|
378 |
9787 |
p. 227-
1 p.
|
artikel
|
| 6 |
Body-mass index, abdominal adiposity, and cardiovascular risk
|
Yusuf, Salim
|
|
2011
|
378 |
9787 |
p. 226-227
2 p.
|
artikel
|
| 7 |
Body-mass index, abdominal adiposity, and cardiovascular risk – Authors' reply
|
Wormser, David
|
|
2011
|
378 |
9787 |
p. 228-
1 p.
|
artikel
|
| 8 |
Building the momentum to prevent HIV in MSM
|
Coates, Thomas J
|
|
2011
|
378 |
9787 |
p. 217-
1 p.
|
artikel
|
| 9 |
Can further placebo-controlled trials of antiretroviral drugs to prevent sexual transmission of HIV be justified?
|
Kuhn, Louise
|
|
2011
|
378 |
9787 |
p. 285-287
3 p.
|
artikel
|
| 10 |
Cardiovascular disease in women—often silent and fatal
|
The Lancet,
|
|
2011
|
378 |
9787 |
p. 200-
1 p.
|
artikel
|
| 11 |
Department of Error
|
|
|
2011
|
378 |
9787 |
p. 228-
1 p.
|
artikel
|
| 12 |
Department of Error
|
|
|
2011
|
378 |
9787 |
p. 228-
1 p.
|
artikel
|
| 13 |
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
|
Karim, Salim S Abdool
|
|
2011
|
378 |
9787 |
p. 279-281
3 p.
|
artikel
|
| 14 |
Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study
|
Tanser, Frank
|
|
2011
|
378 |
9787 |
p. 247-255
9 p.
|
artikel
|
| 15 |
Great Ormond Street Hospital and its management team
|
Blackstone, Tessa
|
|
2011
|
378 |
9787 |
p. 223-224
2 p.
|
artikel
|
| 16 |
HIV/AIDS and the road to Rome
|
The Lancet,
|
|
2011
|
378 |
9787 |
p. 199-
1 p.
|
artikel
|
| 17 |
HIV prevention transformed: the new prevention research agenda
|
Padian, Nancy S
|
|
2011
|
378 |
9787 |
p. 269-278
10 p.
|
artikel
|
| 18 |
HPTN 052 and the future of HIV treatment and prevention
|
Cates, Willard
|
|
2011
|
378 |
9787 |
p. 224-225
2 p.
|
artikel
|
| 19 |
HPTN 052 and the future of HIV treatment and prevention
|
Epstein, Helen
|
|
2011
|
378 |
9787 |
p. 225-
1 p.
|
artikel
|
| 20 |
HPTN 052 and the future of HIV treatment and prevention
|
Seale, Andy
|
|
2011
|
378 |
9787 |
p. 226-
1 p.
|
artikel
|
| 21 |
Kamiar and Arash Alaei: championing HIV/AIDS initiatives in Iran
|
Shetty, Priya
|
|
2011
|
378 |
9787 |
p. 219-
1 p.
|
artikel
|
| 22 |
Let there be light: The Wakley Prize 2011
|
Boyce, Niall
|
|
2011
|
378 |
9787 |
p. 211-
1 p.
|
artikel
|
| 23 |
Offline: A seeker of silences
|
Horton, Richard
|
|
2011
|
378 |
9787 |
p. 212-
1 p.
|
artikel
|
| 24 |
Peter John Iliff
|
Watts, Geoff
|
|
2011
|
378 |
9787 |
p. 222-
1 p.
|
artikel
|
| 25 |
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
|
Schouten, Erik J
|
|
2011
|
378 |
9787 |
p. 282-284
3 p.
|
artikel
|
| 26 |
Quest for an effective AIDS vaccine takes a new tack
|
Maurice, John
|
|
2011
|
378 |
9787 |
p. 213-214
2 p.
|
artikel
|
| 27 |
Radiology service at Great Ormond Street Hospital
|
Chong, Kling
|
|
2011
|
378 |
9787 |
p. 224-
1 p.
|
artikel
|
| 28 |
Response to Correspondence on Great Ormond Street Hospital
|
Holt, Kim
|
|
2011
|
378 |
9787 |
p. 223-
1 p.
|
artikel
|
| 29 |
Rilpivirine: a step forward in tailored HIV treatment
|
Schrijvers, Rik
|
|
2011
|
378 |
9787 |
p. 201-203
3 p.
|
artikel
|
| 30 |
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
|
Molina, Jean-Michel
|
|
2011
|
378 |
9787 |
p. 238-246
9 p.
|
artikel
|
| 31 |
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
|
Cohen, Calvin J
|
|
2011
|
378 |
9787 |
p. 229-237
9 p.
|
artikel
|
| 32 |
Should health professionals play the global health security card?
|
Elbe, Stefan
|
|
2011
|
378 |
9787 |
p. 220-221
2 p.
|
artikel
|
| 33 |
Test and treat in HIV: success could depend on rapid detection
|
Cohen, Ted
|
|
2011
|
378 |
9787 |
p. 204-206
3 p.
|
artikel
|
| 34 |
The concurrency debate: time to put it to rest
|
Padian, Nancy S
|
|
2011
|
378 |
9787 |
p. 203-204
2 p.
|
artikel
|
| 35 |
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study
|
Powers, Kimberly A
|
|
2011
|
378 |
9787 |
p. 256-268
13 p.
|
artikel
|
| 36 |
Treatment as prevention—a double hat-trick
|
Montaner, Julio SG
|
|
2011
|
378 |
9787 |
p. 208-209
2 p.
|
artikel
|
| 37 |
Treatment 2.0: catalysing the next phase of scale-up
|
Hirnschall, Gottfried
|
|
2011
|
378 |
9787 |
p. 209-211
3 p.
|
artikel
|
| 38 |
Uncommon reaction to a common prescription
|
Khodakaram, Kaveh
|
|
2011
|
378 |
9787 |
p. 288-
1 p.
|
artikel
|
| 39 |
Warning: a hard habit to break
|
The Lancet,
|
|
2011
|
378 |
9787 |
p. 200-
1 p.
|
artikel
|
Tijdschrift beschrijving